𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adjuvant therapy and long-term management of differentiated thyroid carcinoma

✍ Scribed by Steven I. Sherman


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
28 KB
Volume
16
Category
Article
ISSN
8756-0437

No coin nor oath required. For personal study only.

✦ Synopsis


As with most therapies for differentiated thyroid carcinoma, there is little consensus about optimal use of postoperative adjuvant therapies or long-term follow-up strategies. However, an increasing body of data indicates that most patients can benefit from postoperative radioiodine ablation followed by thyroid hormone suppression therapy. An approach to long-term monitoring and therapy is provided, including the use of strategies dependent upon the extent of the patient's initial disease.


πŸ“œ SIMILAR VOLUMES


Long-term results in elderly patients wi
✍ Louiza Vini; Stephen L. Hyer; Jennifer Marshall; Roger A'Hern; Clive Harmer πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 93 KB

## Abstract ## BACKGROUND The authors assessed the biologic behavior of differentiated thyroid carcinoma in patients age 70 years or older and evaluated factors that influenced long‐term survival. ## METHODS Among 1448 patients with differentiated thyroid carcinoma who were treated at the author